WO2006036144A8 - Carrier-free composition for the treatment of onychomycosis - Google Patents

Carrier-free composition for the treatment of onychomycosis

Info

Publication number
WO2006036144A8
WO2006036144A8 PCT/US2004/031630 US2004031630W WO2006036144A8 WO 2006036144 A8 WO2006036144 A8 WO 2006036144A8 US 2004031630 W US2004031630 W US 2004031630W WO 2006036144 A8 WO2006036144 A8 WO 2006036144A8
Authority
WO
WIPO (PCT)
Prior art keywords
onychomycosis
carrier
treatment
free composition
composition
Prior art date
Application number
PCT/US2004/031630
Other languages
French (fr)
Other versions
WO2006036144A1 (en
Inventor
Muraleedharan G Nair
Original Assignee
Univ Michigan State
Muraleedharan G Nair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan State, Muraleedharan G Nair filed Critical Univ Michigan State
Priority to PCT/US2004/031630 priority Critical patent/WO2006036144A1/en
Priority to AU2004323577A priority patent/AU2004323577B2/en
Priority to CA002581606A priority patent/CA2581606A1/en
Priority to JP2007533444A priority patent/JP2008514596A/en
Priority to EP04789085A priority patent/EP1796703A4/en
Publication of WO2006036144A1 publication Critical patent/WO2006036144A1/en
Publication of WO2006036144A8 publication Critical patent/WO2006036144A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A composition for the treatment of onychomycosis (fungal nail disease) is described. The composition consists essentially of thymol, camphor, menthol and Eucalyptus citridiora as a colorless liquid oil without any carrier or solvent for these ingredients.
PCT/US2004/031630 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis WO2006036144A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/US2004/031630 WO2006036144A1 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis
AU2004323577A AU2004323577B2 (en) 2004-09-24 Carrier-free composition for the treatment of onychomycosis
CA002581606A CA2581606A1 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis
JP2007533444A JP2008514596A (en) 2004-09-24 2004-09-24 Composition without carrier for the treatment of onychomycosis
EP04789085A EP1796703A4 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/031630 WO2006036144A1 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis

Publications (2)

Publication Number Publication Date
WO2006036144A1 WO2006036144A1 (en) 2006-04-06
WO2006036144A8 true WO2006036144A8 (en) 2007-06-14

Family

ID=36119190

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/031630 WO2006036144A1 (en) 2004-09-24 2004-09-24 Carrier-free composition for the treatment of onychomycosis

Country Status (4)

Country Link
EP (1) EP1796703A4 (en)
JP (1) JP2008514596A (en)
CA (1) CA2581606A1 (en)
WO (1) WO2006036144A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
DE202010012041U1 (en) 2010-08-31 2010-11-18 Sanderstrothmann Gmbh Preparation for nail care
CN103893599A (en) * 2014-04-12 2014-07-02 张军 External traditional Chinese medicine lotion for treating onychomycosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
AU3221497A (en) * 1997-05-30 1998-12-30 Procter & Gamble Company, The Disinfecting compositions and processes for disinfecting surfaces
JP2000128800A (en) * 1998-10-16 2000-05-09 Hideyo Yamaguchi Prevention of infection of dermatophytosis and/or its treatment and tool and material for treatment
US6344190B1 (en) * 1999-02-08 2002-02-05 Board Of Trustees Of Michigan State University Method and compositions for treatment of fungal nail disease
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
JP2003073290A (en) * 2001-08-31 2003-03-12 Kao Corp Composition for external preparation

Also Published As

Publication number Publication date
EP1796703A4 (en) 2009-07-01
JP2008514596A (en) 2008-05-08
WO2006036144A1 (en) 2006-04-06
CA2581606A1 (en) 2006-04-06
AU2004323577A1 (en) 2006-04-06
EP1796703A1 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
WO2005018574A3 (en) Immunostimulatory combinations and treatments
DE60236541D1 (en) INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE TYPE 1
BRPI0510428A (en) methadone topical compositions and processes for using them
WO2005067546A3 (en) Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
BRPI0409516A (en) composition, use of a composition and process for enhancing penetration of a pharmaceutical active
BRPI0410555A (en) solid preparation
BRPI0418099A (en) compounds, pharmaceutical composition, and use of a compound
PT2465493E (en) Topical compositions for the prevention and treatment of irritation of mucous cells
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
EP1637132A4 (en) External preparation for athlete´s foot treatment
WO2002067886A3 (en) Skin composition
TW200502009A (en) Anti-inflammation pain-relieved patch
WO2006131401A3 (en) Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
UA87312C2 (en) COMPOSITION FOR AEROSOL INHALATION OF β-AGONISTS
WO2004091591A3 (en) Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
DE602005003138D1 (en) SPRAYFORM COMPOSITION COMPRISING A CLOBETASOLPROPIONATE AND CALCITRIOL COMBINATION, ALCOHOL PHASE AND OIL PHASE
WO2003017966A3 (en) Use of luffa cylindrica oil in cosmetic and dermopharmaceutical compositions
WO2003028635A3 (en) Pullulan and polyvinyl alcohol based film forming compositions
BRPI0518554A2 (en) use of a pde3 inhibitor
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
BRPI0515181A (en) sterile oil-in-water composition for intravenous administration, use of a monoglyceride and process for preparing a composition for intravenous administration
DK1139980T3 (en) Cosmetic or medical device for topical use
WO2006036144A8 (en) Carrier-free composition for the treatment of onychomycosis
WO2006002846A3 (en) New analogs of nitrobenzylthioinosine
WO2005037772A3 (en) Novel ligand activating receptors rars used for human medicine and cosmetics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2581606

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007533444

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2004323577

Country of ref document: AU

Ref document number: 2004789085

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004789085

Country of ref document: EP